NFKB1 and cancer: Therefore, the observed association between the −94ins/del ATTG polymorphism and cancer risk can be accounted for by the insertion allele that can inhibit apoptosis and promote cellular proliferation by upregulating the expression of p50 (NFKB1) [8, 12, 17], which was implicated in the abovementioned mechanism.